- Home
- KPRX vs SGN Comparison
KPRX vs SGN Comparison
Compare KPRX & SGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPRX
- SGN
- Stock Information
- Founded
- KPRX 1998
- SGN 2019
- Country
- KPRX United States
- SGN United States
- Employees
- KPRX N/A
- SGN N/A
- Industry
- KPRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SGN
- Sector
- KPRX Health Care
- SGN
- Exchange
- KPRX Nasdaq
- SGN Nasdaq
- Market Cap
- KPRX 9.2M
- SGN 7.8M
- IPO Year
- KPRX N/A
- SGN 2023
- Fundamental
- Price
- KPRX $2.75
- SGN $1.78
- Analyst Decision
- KPRX Strong Buy
- SGN
- Analyst Count
- KPRX 1
- SGN 0
- Target Price
- KPRX $10.00
- SGN N/A
- AVG Volume (30 Days)
- KPRX 35.6K
- SGN 245.7K
- Earning Date
- KPRX 11-07-2025
- SGN 11-13-2025
- Dividend Yield
- KPRX N/A
- SGN N/A
- EPS Growth
- KPRX N/A
- SGN N/A
- EPS
- KPRX N/A
- SGN N/A
- Revenue
- KPRX N/A
- SGN $391,126.00
- Revenue This Year
- KPRX N/A
- SGN N/A
- Revenue Next Year
- KPRX N/A
- SGN N/A
- P/E Ratio
- KPRX N/A
- SGN N/A
- Revenue Growth
- KPRX N/A
- SGN N/A
- 52 Week Low
- KPRX $2.25
- SGN $0.44
- 52 Week High
- KPRX $4.18
- SGN $13.72
- Technical
- Relative Strength Index (RSI)
- KPRX 55.26
- SGN 50.42
- Support Level
- KPRX $2.67
- SGN $1.69
- Resistance Level
- KPRX $2.89
- SGN $2.08
- Average True Range (ATR)
- KPRX 0.11
- SGN 0.15
- MACD
- KPRX 0.02
- SGN -0.02
- Stochastic Oscillator
- KPRX 70.26
- SGN 24.49
About KPRX Kiora Pharmaceuticals Inc.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
About SGN Signing Day Sports Inc.
Signing Day Sports Inc is a technology company developing and operating platforms aiming to allow significantly more student-athletes to go to college and continue playing sports. Its platform Signing Day Sports is a digital ecosystem to help athletes get discovered and recruited by coaches and recruiters across the country. It currently fully supports football and baseball, and it plans to expand the Signing Day Sports platform to include additional sports.